Literature DB >> 22608259

An emerging role of RNA-binding proteins as multifunctional regulators of lymphocyte development and function.

Martin Turner1, Daniel J Hodson.   

Abstract

Sequence-specific RNA-binding proteins (RBP) and the regulation of RNA decay have long been recognized as important regulators of the inflammatory response. RBP influence gene expression throughout the lifespan of the mRNA by regulating splicing, polyadenylation, cellular localization, translation, and decay. Increasing evidence now indicates that these proteins, together with the RNA decay machinery that they recruit, also regulate the development and activation of lymphocytes. The activity of RBP is regulated by the same signal transduction pathways that govern lymphocyte development and differentiation in response to antigen and cytokine receptor engagement. Roles for these proteins in regulating the diverse functions of lymphocytes are becoming increasingly apparent.
Copyright © 2012 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22608259     DOI: 10.1016/B978-0-12-394299-9.00006-0

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  9 in total

Review 1.  Post-transcriptional regulation of cytokine signaling by AU-rich and GU-rich elements.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  J Interferon Cytokine Res       Date:  2014-04       Impact factor: 2.607

Review 2.  The role of RNA-binding protein tristetraprolin in cancer and immunity.

Authors:  Jian Guo; Huiheng Qu; Ye Chen; Jiazeng Xia
Journal:  Med Oncol       Date:  2017-11-09       Impact factor: 3.064

3.  Cytoplasmic Rbfox1 Regulates the Expression of Synaptic and Autism-Related Genes.

Authors:  Ji-Ann Lee; Andrey Damianov; Chia-Ho Lin; Mariana Fontes; Neelroop N Parikshak; Erik S Anderson; Daniel H Geschwind; Douglas L Black; Kelsey C Martin
Journal:  Neuron       Date:  2015-12-10       Impact factor: 17.173

4.  B Cell-Intrinsic Expression of the HuR RNA-Binding Protein Is Required for the T Cell-Dependent Immune Response In Vivo.

Authors:  Amy DeMicco; Martin S Naradikian; Vishal J Sindhava; Je-Hyun Yoon; Myriam Gorospe; Gerald B Wertheim; Michael P Cancro; Craig H Bassing
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

5.  "Protein aggregates" contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation.

Authors:  Robert J Shmookler Reis; Ramani Atluri; Meenakshisundaram Balasubramaniam; Jay Johnson; Akshatha Ganne; Srinivas Ayyadevara
Journal:  Aging Cell       Date:  2021-03-31       Impact factor: 9.304

6.  Oncoprotein AEG-1 is an endoplasmic reticulum RNA-binding protein whose interactome is enriched in organelle resident protein-encoding mRNAs.

Authors:  Jack C-C Hsu; David W Reid; Alyson M Hoffman; Devanand Sarkar; Christopher V Nicchitta
Journal:  RNA       Date:  2018-02-07       Impact factor: 4.942

Review 7.  MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression.

Authors:  Sourabh Soni; Prince Anand; Yogendra S Padwad
Journal:  J Exp Clin Cancer Res       Date:  2019-03-08

8.  Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression.

Authors:  Ruben G de Bruin; Lily Shiue; Jurriën Prins; Hetty C de Boer; Anjana Singh; W Samuel Fagg; Janine M van Gils; Jacques M G J Duijs; Sol Katzman; Adriaan O Kraaijeveld; Stefan Böhringer; Wai Y Leung; Szymon M Kielbasa; John P Donahue; Patrick H J van der Zande; Rick Sijbom; Carla M A van Alem; Ilze Bot; Cees van Kooten; J Wouter Jukema; Hilde Van Esch; Ton J Rabelink; Hilal Kazan; Erik A L Biessen; Manuel Ares; Anton Jan van Zonneveld; Eric P van der Veer
Journal:  Nat Commun       Date:  2016-03-31       Impact factor: 14.919

9.  The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation.

Authors:  James La Porta; Rodrigo Matus-Nicodemos; Aníbal Valentín-Acevedo; Lori R Covey
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.